Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 11Neoplasms 5Cancer Pain 4Pain, Postoperative 2Malignant Female Reproductive System Neoplasm 2Hematologic Neoplasms 2Emergencies 2Agnosia 2Uterine Cervical Neoplasms 1Tumor Surgery 1Sarcoma 1Rectal Neoplasms 1Pulmonary Nodule 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Pain, Intractable 1Ovarian Neoplasms 1Neuralgia 1Neoplasm Metastasis 1Mucositis 1Lymphoma, Follicular 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Intraoperative Complications 1Ileus 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Duodenal Neoplasms 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Hydromorphone × Clear all
NCT07315022 2026-01-02

Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma

First Affiliated Hospital, Sun Yat-Sen University

Phase 4 Completed
129 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡